Title Phenotype Institution Algorithm Type Total Cases Total Controls PPVsort descending Sensitivity
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 1.00, 0.96
Implementation For Phase 3 eMERGE Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia Geisinger Case, Control 25 25 1.00, 0.96
GH/UW Verification Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm Group Health and University of Washington Case, Control 479 319 1.00, 1.00 1.00, 1.00
Geisinger Impl Colorectal Cancer (CRC) Geisinger Case, Control 25 25 1.00, 1.00
Cardiac Conduction Marshfield Implementation Cardiac Conduction (QRS) Marshfield Clinic Research Foundation Case Only 1.00
Marshfield diverticulosis/diverticulitis implementation Diverticulosis and Diverticulitis Marshfield Clinic Research Foundation Case, Control 50 50 1.00, 1.00
T2D Vanderbilt Implementation Type 2 Diabetes Mellitus Vanderbilt University Case, Control 1.00, 1.00
Validation of Asthma algorithm - Geisinger Asthma Geisinger Case, Control 10 10 1.00, 1.00
Group Health Implementation of Atopic Dermatitis Algorithm Atopic Dermatitis Algorithm Group Health Cooperative Case, Control 206 207 1.00, 1.00 1.00
KPWA/UW (primary site) implementation Depression KPWA/UW Case, Control 1,999 4,268 1.00, 1.00 1.00, 1.00
Marshfield Hearing loss validation Hearing Loss Marshfield Clinic Research Foundation Case, Control 25 25 1.00, 1.00
Vanderbilt implementation Clostridium Difficile Colitis Case, Control 1.00, 1.00
Marshfield AAA implementation Abdominal Aortic Aneurysm ( AAA ) Marshfield Clinic Research Foundation Case, Control 25 22 1.00, 1.00
Marshfield implementation CAAD (Carotid Artery Atherosclerosis Disease) Marshfield Clinic Research Foundation Case, Control 71 435 1.00, 1.00 1.00
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 1.00, 1.00
caMRSA chart verification caMRSA GHRI/UW Case, Control 72 2,310 1.00, 1.00 1.00, 1.00
Marshfield implementation caMRSA Marshfield Clinic Research Foundation Case, Control 1.00, 1.00 1.00, 1.00
Marshfield Implementation 2 CAAD (Carotid Artery Atherosclerosis Disease) Marshfield Clinic Research Foundation Case, Control 193 4,170 1.00, 1.00
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 1.00, 1.00 1.00, 1.00
Mayo Clinic CAAD Evaluation CAAD (Carotid Artery Atherosclerosis Disease) Mayo Clinic Case, Control 1.00 0.72
NU appendicitis cases Appendicitis Northwestern University Case Only 30 1.00
CHOP NAFLD Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) CHOP Case Only 12 1.00
Mayo CAAD cases and controls CAAD (Carotid Artery Atherosclerosis Disease) Mayo Case, Control 13 1.00 0.71
Group Health and UW Zoster Implementation Herpes Zoster Group Health and UW Case, Control 25 25 1.00, 0.96 1.00
Marshfield Zoster implementation Herpes Zoster Marshfield Clinic Research Foundation Case, Control 10 10 1.00, 1.00

Pages